AstraZeneca India Private Limited (AZIPL) has announced a Rs 250 crore ($30 million) investment to expand its Global Innovation and Technology Centre (GITC) in Chennai, Tamil Nadu. The expansion aims to add nearly 1,300 roles focused on driving innovation and enhancing operational efficiency globally.
The inauguration ceremony of the expanded facility was officiated by Dr TRB Rajaa, Minister of Industries, Tamil Nadu, Christina Scott CMG, British Deputy High Commissioner to India, Sylvia Varela, AstraZeneca Vice President for Asia Area, and AstraZeneca’s leadership team in the country.
This investment marks a significant milestone for AstraZeneca in India as it celebrates its 45th year in the country. By 2025, the expanded GITC plans to bring in highly skilled professionals and utilize technologies such as artificial intelligence, machine learning, data science, and supply chain analytics to advance healthcare outcomes.
Dr Sanjeev Panchal, Managing Director & Country President, AstraZeneca Pharma India Limited (AZPIL), emphasized India’s robust talent pool and dynamic digital ecosystem, positioning it as a crucial hub for global operations. This strategic investment underscores AstraZeneca’s commitment to enhancing patient outcomes through cutting-edge technology.
MK Stalin, Chief Minister of Tamil Nadu, highlighted Tamil Nadu’s dedication to becoming a hub for technology and research. The collaboration with AstraZeneca aims to foster innovation and create high-value opportunities. Dr Rajaa acknowledged AstraZeneca’s confidence in Tamil Nadu’s talent pool and business environment, underscoring Chennai’s emergence as India’s GCC Capital and its role in driving economic growth and technological advancement.
